The change of blood pressure. حسب Pitchaporn Sonuch (11785736)

"…</p><p>Conclusions</p><p>The combined intervention significantly decreased systolic blood pressure and showed a trend towards reduced urine sodium excretion in hypertensive patients. …"

<i>hdc</i> silencing causes cell death and cell cycle arrest in the PSC. حسب Bayan Kharrat (19959505)

Patient flowchart. حسب Anna D. Ware (19688153)

"…Preexisting aspirin prescription was associated with a significant decrease risk of post-COVID-19 thromboembolic disorders, including pulmonary embolism (OR [95% CI]: 0.69 [0.65, 0.74]) and deep vein thrombosis (OR [95% CI]: 0.76 [0.69, 0.83], but an increased risk of acute arterial diseases, including ischemic stroke (OR [95% CI]: 1.54 [1.46, 1.60]) and acute ischemic heart disease (1.33 [1.26, 1.39]).…"

Oscillatory potential (OP) analysis of 6-, 9-, and 12-month ERGs shows continued dysfunction in the inner retina reflecting A- and B-wave results. حسب Shaylah McCool (20818280)

"…<p>(A) Example OP traces from C57 (black) and 5xFAD (blue) mice at 3 timepoints show significantly increased OP amplitudes in the 6-month 5xFAD mice and significantly decreased OP amplitudes in the 9-month 5xFAD mice. …"

PRISMA flowchart of the included studies. حسب Gaelle Salame (21077899)

"…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …"

Characteristics of Included Studies. حسب Gaelle Salame (21077899)

"…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …"

Numbers of nuclei and centrioles per cell. حسب Yang-In Yim (324355)

"…Note that the values in (D) for HSET KD and combined KD of Myo10 KD and HSET, while significantly different from the control, represent decreases in centriole number, not increases (these decreases may be due to the anti-proliferative effects of HSET KD). …"

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. حسب Tobias G. Schips (21799838)

Supplementary Material for: Association of platelet count and mean platelet volume with fish intake frequency: Implication for the cardioprotective effect of fish intake حسب figshare admin karger (2628495)

"…Introduction: Mean platelet volume (MPV) measures platelet activity, and high values indicate increased atherosclerotic cardiovascular disease (ASCVD) risk. …"

S1 Graphical abstract - حسب Hai Nguyen Ngoc Dang (19200560)

"…Furthermore, the median aortic compliance (AC, 10^-2mm/mmHg) and aortic distensibility (AD, 10^-3mmHg^-1) in individuals with T2DM were 4.07 (2.28–7.44) and 3.08 (1.57–5.26), respectively, lower than those in the control group, with median values of 6.40 (3.08–10.75) and 5.33 (2.80–9.79). A longer diabetes duration was linked to a greater ASI (r = 0.43, p < 0.05), while the AS decreased (r = -0.37, p < 0.05).…"

(a) Taylor diagrams of Khandelwal et al. [13], Brabdas et al, Kumar et al. [12] models. (b) Taylor diagrams of Ranjbar-Karami et al. [14], Christaras et al. [52], Feng et al. [16],... حسب Fahd Saeed Alakbari (10701871)

Movement variability conditioned on task outcome. حسب Adam M. Roth (19845864)

Image 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Image 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Table 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.docx حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Table 10_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Table 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Table 7_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Image 8_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"

Table 6_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc حسب Yu Zhang (12946)

"…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …"